54 related articles for article (PubMed ID: 30170989)
1. Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome.
Cattrini C; Rubagotti A; Nuzzo PV; Zinoli L; Salvi S; Boccardo S; Perachino M; Cerbone L; Vallome G; Latocca MM; Zanardi E; Boccardo F
Clin Genitourin Cancer; 2018 Dec; 16(6):e1257-e1265. PubMed ID: 30170989
[TBL] [Abstract][Full Text] [Related]
2. Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry.
Biggs CN; Siddiqui KM; Al-Zahrani AA; Pardhan S; Brett SI; Guo QQ; Yang J; Wolf P; Power NE; Durfee PN; MacMillan CD; Townson JL; Brinker JC; Fleshner NE; Izawa JI; Chambers AF; Chin JL; Leong HS
Oncotarget; 2016 Feb; 7(8):8839-49. PubMed ID: 26814433
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy.
Antonarakis ES; Keizman D; Zhang Z; Gurel B; Lotan TL; Hicks JL; Fedor HL; Carducci MA; De Marzo AM; Eisenberger MA
Cancer; 2012 Dec; 118(24):6063-71. PubMed ID: 22674438
[TBL] [Abstract][Full Text] [Related]
4. Histological parameters and stromal desmoplastic status affecting accurate diagnosis of extraprostatic extension of prostate cancer using multi-parametric magnetic resonance imaging.
Okano K; Miyai K; Mikoshi A; Edo H; Ito K; Tsuda H; Shinmoto H
Int J Urol; 2024 May; 31(5):475-482. PubMed ID: 38193247
[TBL] [Abstract][Full Text] [Related]
5. Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer.
Lo Iacono M; Buttigliero C; Monica V; Bollito E; Garrou D; Cappia S; Rapa I; Vignani F; Bertaglia V; Fiori C; Papotti M; Volante M; Scagliotti GV; Porpiglia F; Tucci M
Oncotarget; 2016 Mar; 7(12):14394-404. PubMed ID: 26887047
[TBL] [Abstract][Full Text] [Related]
6. Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness.
Liu Y; Chen J; Sethi A; Li QK; Chen L; Collins B; Gillet LC; Wollscheid B; Zhang H; Aebersold R
Mol Cell Proteomics; 2014 Jul; 13(7):1753-68. PubMed ID: 24741114
[TBL] [Abstract][Full Text] [Related]
7. Stroma-derived extracellular vesicle mRNA signatures inform histological nature of prostate cancer.
Shephard AP; Giles P; Mbengue M; Alraies A; Spary LK; Kynaston H; Gurney MJ; Falcón-Pérez JM; Royo F; Tabi Z; Parthimos D; Errington RJ; Clayton A; Webber JP
J Extracell Vesicles; 2021 Oct; 10(12):e12150. PubMed ID: 34596356
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma.
Estephan F; Lap CJ; Banagan J; Antonio M; Liu S; Diao G; Rozalen AZ; Rajendran R; Krasnow S; Subrahmanyam R; Nava VE; Jain M
Ann Diagn Pathol; 2023 Dec; 67():152219. PubMed ID: 38622987
[TBL] [Abstract][Full Text] [Related]
9. Patterns of B-cell lymphocyte expression changes in pre- and post-malignant prostate tissue are associated with prostate cancer progression.
Sadasivan SM; Loveless IM; Chen Y; Gupta NS; Sanii R; Bobbitt KR; Chitale DA; Williamson SR; Rundle AG; Rybicki BA
Cancer Med; 2024 Mar; 13(6):e7118. PubMed ID: 38523528
[TBL] [Abstract][Full Text] [Related]
10. Stem cells: The root of prostate cancer?
Kasper S
J Cell Physiol; 2008 Aug; 216(2):332-6. PubMed ID: 18459113
[TBL] [Abstract][Full Text] [Related]
11. Soluble Periostin is a potential surveillance biomarker for early and long-term response to chemotherapy in advanced breast cancer.
Jia L; Hu W; Yan X; Shao J; Guo Y; Zhang A; Yu L; Zhou Y; Li Y; Ren L; Dong D
Cancer Cell Int; 2024 Mar; 24(1):109. PubMed ID: 38504252
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin receptor autoantibodies as exposures that modify disease progression: Cross sectional, longitudinal and
Jain A; Shah H; Simonsick EM; Metter EJ; Mangold L; Humphreys E; Partin A; Fedarko NS
J Transl Autoimmun; 2019 Dec; 2():. PubMed ID: 31930191
[TBL] [Abstract][Full Text] [Related]
13. An insight into the diagnostic, prognostic, and taxanes resistance of double zinc finger and homeodomain factor
Said R; Hernández-Losa J; Jenni R; de Haro RSL; Moline T; Zouari S; Blel A; Rammeh S; Derouiche A; Ouerhani S
3 Biotech; 2024 Apr; 14(4):106. PubMed ID: 38476644
[TBL] [Abstract][Full Text] [Related]
14. Combined loss of TFF3 and PTEN is associated with lethal outcome and overall survival in men with prostate cancer.
Abou-Ouf H; Ghosh S; Box A; Palanisamy N; Bismar TA
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1751-1759. PubMed ID: 31129769
[TBL] [Abstract][Full Text] [Related]
15. Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer.
Cattrini C; Barboro P; Rubagotti A; Zinoli L; Zanardi E; Capaia M; Boccardo F
Transl Oncol; 2020 Jul; 13(7):100789. PubMed ID: 32416542
[TBL] [Abstract][Full Text] [Related]
16. High-level expression of periostin is significantly correlated with tumor angiogenesis in prostate cancer.
Sun F; Hu Q; Zhu Y; Guo Y; Mi Y; Sun C; Xia G
Int J Clin Exp Pathol; 2018; 11(3):1569-1574. PubMed ID: 31938255
[TBL] [Abstract][Full Text] [Related]
17. The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery.
Samaržija I
Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38255186
[TBL] [Abstract][Full Text] [Related]
18. Periostin: biology and function in cancer.
Dorafshan S; Razmi M; Safaei S; Gentilin E; Madjd Z; Ghods R
Cancer Cell Int; 2022 Oct; 22(1):315. PubMed ID: 36224629
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of stromal periostin expression in upper urinary tract urothelial carcinoma.
Miyai K; Kawamura K; Ito K; Matsukuma S; Tsuda H
BMC Cancer; 2022 Jul; 22(1):787. PubMed ID: 35850759
[TBL] [Abstract][Full Text] [Related]
20. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
